Bank of Montreal’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,858
| Closed | -$208K | – | 3987 |
|
|
2025
Q4 | $208K | Buy |
+4,858
| New | +$183K | ﹤0.01% | 2820 |
|
|
2024
Q1 | – | Sell |
-1,072
| Closed | -$16.7K | – | 4253 |
|
|
2023
Q4 | $16.7K | Buy |
+1,072
| New | +$11K | ﹤0.01% | 3742 |
|
|
2023
Q3 | – | Sell |
-1,007
| Closed | -$16.2K | – | 4153 |
|
|
2023
Q2 | $16.2K | Sell |
1,007
-812
| -45% | -$11K | ﹤0.01% | 3753 |
|
|
2023
Q1 | $24.2K | Buy |
1,819
+716
| +65% | +$11.4K | ﹤0.01% | 3495 |
|
|
2022
Q4 | $16.7K | Buy |
1,103
+60
| +6% | +$550 | ﹤0.01% | 3716 |
|
|
2022
Q3 | $17 | Buy |
1,043
+16
| +2% | +$216 | ﹤0.01% | 3822 |
|
|
2022
Q2 | $12 | Sell |
1,027
-72
| -7% | -$1.45K | ﹤0.01% | 3832 |
|
|
2022
Q1 | $35K | Sell |
1,099
-423
| -28% | -$11.5K | ﹤0.01% | 3844 |
|
|
2021
Q4 | $41K | Sell |
1,522
-30,467
| -95% | -$919K | ﹤0.01% | 3265 |
|
|
2021
Q3 | $1.28M | Sell |
31,989
-1,229
| -4% | -$48.4K | ﹤0.01% | 2336 |
|
|
2021
Q2 | $1.51M | Buy |
33,218
+8,608
| +35% | +$325K | ﹤0.01% | 2226 |
|
|
2021
Q1 | $818K | Sell |
24,610
-8,665
| -26% | -$343K | ﹤0.01% | 2345 |
|
|
2020
Q4 | $1.14M | Buy |
33,275
+9,369
| +39% | +$271K | ﹤0.01% | 2154 |
|
|
2020
Q3 | $603K | Sell |
23,906
-17,492
| -42% | -$429K | ﹤0.01% | 2243 |
|
|
2020
Q2 | $754K | Buy |
41,398
+8,737
| +27% | +$157K | ﹤0.01% | 2064 |
|
|
2020
Q1 | $467K | Buy |
32,661
+55
| +0.2% | +$1.17K | ﹤0.01% | 2010 |
|
|
2019
Q4 | $698K | Buy |
32,606
+30,775
| +1,681% | +$634K | ﹤0.01% | 2476 |
|
|
2019
Q3 | $35K | Buy |
1,831
+131
| +8% | +$2.71K | ﹤0.01% | 3800 |
|
|
2019
Q2 | $44K | Buy |
1,700
+1,387
| +443% | +$31.3K | ﹤0.01% | 3760 |
|
|
2019
Q1 | $8K | Sell |
313
-82
| -21% | -$1.88K | ﹤0.01% | 3940 |
|
|
2018
Q4 | $10K | Sell |
395
-4,829
| -92% | -$136K | ﹤0.01% | 3892 |
|
|
2018
Q3 | $168K | Buy |
5,224
+301
| +6% | +$9.04K | ﹤0.01% | 2850 |
|
|
2018
Q2 | $139K | Buy |
+4,923
| New | +$175K | ﹤0.01% | 2963 |
|
|
2017
Q4 | – | Sell |
-89
| Closed | -$2K | – | 4301 |
|
|
2017
Q3 | $2K | Buy |
89
+87
| +4,350% | +$2.12K | ﹤0.01% | 4044 |
|
|
2017
Q2 | $0 | Buy |
+2
| New | +$55 | ﹤0.01% | 4265 |
|
|
2016
Q4 | – | Sell |
-150
| Closed | -$6K | – | 4166 |
|
|
2016
Q3 | $6K | Buy |
+150
| New | +$4.3K | ﹤0.01% | 3675 |
|
|
2014
Q3 | – | Sell |
-216
| Closed | -$8K | – | 4348 |
|
|
2014
Q2 | $8K | Buy |
+216
| New | +$7.34K | ﹤0.01% | 3970 |
|
|
2013
Q4 | – | Sell |
-138
| Closed | -$5K | – | 3895 |
|
|
2013
Q3 | $5K | Buy |
+138
| New | +$5.04K | ﹤0.01% | 3572 |
|
Other funds holding RIGL
AC
VCM
Bank of Montreal's RIGL Position: Q1 2026 in Review
Bank of Montreal sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 4,858 shares — an estimated $208K sold.
Bank of Montreal first reported a position in RIGL in Q3 2013 and held it in 28 quarters. The position peaked at $1.51M in Q2 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- Bank of Montreal reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Bank of Montreal sold 4,858 Rigel Pharmaceuticals shares in Q1 2026, an estimated $208K.
- Bank of Montreal first reported a position in Rigel Pharmaceuticals in Q3 2013 and held it in 28 quarters.
- Bank of Montreal's Rigel Pharmaceuticals position peaked at $1.51M in Q2 2021.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.